4.5 Article

Protein-protein interaction networks: unraveling the wiring of molecular machines within the cell

Journal

BRIEFINGS IN FUNCTIONAL GENOMICS
Volume 11, Issue 6, Pages 489-496

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/bfgp/els036

Keywords

Interactome; proteomics; protein interaction; network; protein hub; bioinformatics

Funding

  1. Consejo Superior de Investigaciones Cientificas (CSIC) [i-LINK0398]
  2. Spanish Government (ISCiii) [PS09/00843]
  3. European Commission [FP7-HEALTH-2007-223411]

Ask authors/readers for more resources

Mapping and understanding of the protein interaction networks with their key modules and hubs can provide deeper insights into the molecular machinery underlying complex phenotypes. In this article, we present the basic characteristics and definitions of protein networks, starting with a distinction of the different types of associations between proteins. We focus the review on protein-protein interactions (PPIs), a subset of associations defined as physical contacts between proteins that occur by selective molecular docking in a particular biological context. We present such definition as opposed to other types of protein associations derived from regulatory, genetic, structural or functional relations. To determine PPIs, a variety of binary and co-complex methods exist; however, not all the technologies provide the same information and data quality. A way of increasing confidence in a given protein interaction is to integrate orthogonal experimental evidences. The use of several complementary methods testing each single interaction assesses the accuracy of PPI data and tries to minimize the occurrence of false interactions. Following this approach there have been important efforts to unify primary databases of experimentally proven PPIs into integrated databases. These meta-databases provide a measure of the confidence of interactions based on the number of experimental proofs that report them. As a conclusion, we can state that integrated information allows the building of more reliable interaction networks. Identification of communities, cliques, modules and hubs by analysing the topological parameters and graph properties of the protein networks allows the discovery of central/critical nodes, which are candidates to regulate cellular flux and dynamics.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Hematology

Conditional expression of HGAL leads to the development of diffuse large B-cell lymphoma in mice

Javier Raboso-Gallego, Ana Casado-Garcia, Xiaoyu Jiang, Marta Isidro-Hernandez, Andrew J. Gentles, Shuchun Zhao, Yaso Natkunam, Oscar Blanco, Veronica Dominguez, Belen Pintado, Diego Alonso-Lopez, Javier De las Rivas, Carolina Vicente-Duenas, Izidore S. Lossos, Isidro Sanchez-Garcia

Summary: The study shows that constitutive enforced expression of HGAL leads to DLBCL development, and this protein is mainly present in germinal center B lymphocytes.

BLOOD (2021)

Article Oncology

Transient Inhibition of the JAK/STAT Pathway Prevents B-ALL Development in Genetically Predisposed Mice

Ana Casado-Garcia, Marta Isidro-Hernandez, Ninad Oak, Andrea Mayado, Christine Mann-Ran, Javier Raboso-Gallego, Silvia Aleman-Arteaga, Alexandra Buhles, Dario Sterker, Elena G. Sanchez, Jorge Martinez-Cano, Oscar Blanco, Alberto Orfao, Diego Alonso-Lopez, Javier De Las Rivas, Susana Riesco, Pablo Prieto-Matos, Africa Gonzalez-Murillo, Francisco Javier Garcia Criado, Maria Begona Garcia Cenador, Thomas Radimerski, Manuel Ramirez-Orellana, Cesar Cobaleda, Jun J. Yang, Carolina Vicente-Duenas, Andreas Weiss, Kim E. Nichols, Isidro Sanchez-Garcia

Summary: This study demonstrates that early-life administration of the JAK1/2 inhibitor ruxolitinib significantly reduces the risk of B-ALL in mice. This finding presents a potential strategy for preventing the development of B-ALL.

CANCER RESEARCH (2022)

Review Pharmacology & Pharmacy

Hypoxia as a driver of resistance to immunotherapy

Joanna Kopecka, Iris C. Salaroglio, Elizabeth Perez-Ruiz, Ana Bela Sarmento-Ribeiro, Simona Saponara, Javier De Las Rivas, Chiara Riganti

Summary: Hypoxia in solid tumors leads to resistance to immunotherapy, particularly to ICPIs and CAR T-cells, by promoting immunosuppressive populations and angiogenesis. Innovative combination therapies may provide a solution to enhance the efficacy of immunotherapy against hypoxic and therapy-resistant tumors.

DRUG RESISTANCE UPDATES (2021)

Article Immunology

SARS-CoV-2 Infection Triggers Auto-Immune Response in ARDS

Pablo Juanes-Velasco, Alicia Landeira-Vinuela, Marina L. Garcia-Vaquero, Quentin Lecrevisse, Raquel Herrero, Antonio Ferruelo, Rafael Gongora, Fernando Corrales, Javier De Las Rivas, Jose A. Lorente, Angela-Patricia Hernandez, Manuel Fuentes

Summary: This study analyzed the immune profile of severe ARDS in COVID-19 patients using functional proteomics approaches. It found that the autoimmune profiles were correlated with disease severity and clinical progression, providing new perspectives for therapeutic development and biomarker identification in COVID-19 patients.

FRONTIERS IN IMMUNOLOGY (2022)

Review Oncology

Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia-From Molecular Mechanisms to Clinical Relevance

Raquel Alves, Ana Cristina Goncalves, Sergio Rutella, Antonio M. Almeida, Javier De Las Rivas, Ioannis P. Trougakos, Ana Bela Sarmento Ribeiro

Summary: Chronic myeloid leukemia (CML) is associated with a molecular alteration resulting in the BCR-ABL1 fusion gene, and resistance to tyrosine kinase inhibitors (TKIs) such as Imatinib may occur during treatment. Understanding the molecular mechanisms of TKI resistance, in addition to patient adherence, is crucial for managing CML effectively.

CANCERS (2021)

Article Oncology

A Gene Signature Derived from the Loss of CDKN1A (p21) Is Associated with CMS4 Colorectal Cancer

Santiago Bueno-Fortes, Julienne K. Muenzner, Alberto Berral-Gonzalez, Chuanpit Hampel, Pablo Lindner, Alexandra Berninger, Kerstin Huebner, Philipp Kunze, Tobias Baeuerle, Katharina Erlenbach-Wuensch, Jose Manuel Sanchez-Santos, Arndt Hartmann, Javier de las Rivas, Regine Schneider-Stock

Summary: In this study, a gene signature associated with the loss of CDKN1A gene in HCT116 p21-/- colorectal cancer cells is identified and shown to be related to the CMS4 subtype of colon cancer. This gene signature is associated with worse relapse-free and overall survival. The findings provide insights into the molecular mechanisms of epithelial-mesenchymal transition and contribute to our understanding of tumor progression.

CANCERS (2022)

Article Biochemistry & Molecular Biology

Deepening into Intracellular Signaling Landscape through Integrative Spatial Proteomics and Transcriptomics in a Lymphoma Model

Alicia Landeira-Vinuela, Paula Diez, Pablo Juanes-Velasco, Quentin Lecrevisse, Alberto Orfao, Javier de las Rivas, Manuel Fuentes

Summary: The Human Proteome Project systematically characterized the protein landscape using diverse techniques in this study, which focused on a B-cell lymphoma cell line. Through integration of RNA-Seq transcriptomics, MS/MS, and antibody-based affinity proteomics, 5672 unique proteins were identified and further analyzed for insights into protein dynamics at the intracellular level. The study also developed a bioinformatic pipeline for the comprehensive and global characterization of intracellular protein profiles.

BIOMOLECULES (2021)

Article Oncology

Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project

Mattia D'Agostino, David A. Cairns, Juan Jose Lahuerta, Ruth Wester, Uta Bertsch, Anders Waage, Elena Zamagni, Maria-Victoria Mateos, Daniele Dall'Olio, Niels W. C. J. van de Donk, Graham Jackson, Serena Rocchi, Hans Salwender, Joan Blade Creixenti, Bronno van der Holt, Gastone Castellani, Francesca Bonello, Andrea Capra, Elias K. Mai, Jan Durig, Francesca Gay, Sonja Zweegman, Michele Cavo, Martin F. Kaiser, Hartmut Goldschmidt, Jesus Maria Hernandez Rivas, Alessandra Larocca, Gordon Cook, Jesus F. San-Miguel, Mario Boccadoro, Pieter Sonneveld

Summary: In this study, the Revised International Staging system (R-ISS) for intermediate-risk multiple myeloma patients was revised based on the additive value of each single risk feature.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Article Economics

Building a Healthcare Alliance for Resourceful Medicine Offensive Against Neoplasms in Hematology Added Value Framework for Hematologic Malignancies: A Comparative Analysis of Existing Tools

Francesco Cerisoli, Farzad Ali, Tamas Bereczky, Natacha Bolanos, Lars Bullinger, Sujith Dhanasiri, James Gallagher, Sonia Garcia Perez, Jan Geissler, Yann Guillevic, Kathryn Harrison, Anastasia Naoum, Carla Portulano, Ana E. Rodriguez Vicente, Renate Schulze-Rath, Gabriela Yumi Gomez, Guillermo Sanz, Jesus Maria Hernandez Rivas

Summary: The HARMONY project aims to evaluate the suitability of existing value frameworks (VFs) for assessing the clinical and societal impact of new interventions for hematologic malignancies (HMs). Through surveys and questionnaires, the project identified important outcomes and preferred data sources for each HM. The comparative analysis highlights the challenges and opportunities of existing frameworks in the context of HMs and proposes possible actions for creating or integrating a more specific, patient-focused clinical VF.

VALUE IN HEALTH (2022)

Article Immunology

Unravelling soluble immune checkpoints in chronic lymphocytic leukemia: Physiological immunomodulators or immune dysfunction

Alicia Landeira-Vinuela, Carlota Arias-Hidalgo, Pablo Juanes-Velasco, Miguel Alcoceba, Almudena Navarro-Bailon, Carlos Eduardo Pedreira, Quentin Lecrevisse, Laura Diaz-Munoz, Jose Manuel Sanchez-Santos, Angela-Patricia Hernandez, Marina L. Garcia-Vaquero, Rafael Gongora, Javier De Las Rivas, Marcos Gonzalez, Alberto Orfao, Manuel Fuentes

Summary: Chronic lymphocytic leukemia (CLL) is a lymphoid neoplasm characterized by the accumulation of mature B cells. The diagnosis is established by the detection of monoclonal B lymphocytes in peripheral blood, even in early stages [monoclonal B-cell lymphocytosis (MBLhi)], and its clinical course is highly heterogeneous. Multiple prognostic factors, such as immunoglobulin heavy chain variable region (IGHV) mutational status, del17p, and TP53 mutations, are related to the observed genetic heterogeneity. In addition, dysregulation of the immune system and the complexity of the tumor microenvironment play critical roles in the onset, progression, and therapy response of CLL.

FRONTIERS IN IMMUNOLOGY (2022)

Article Biochemical Research Methods

Exploring High-Throughput Immunoassays for Biomarker Validation in Rheumatic Diseases in the Context of the Human Proteome Project

Manuel Fuentes, Cristina Ruiz-Romero, Sara Misiego, Pablo Juanes-Velasco, Alicia Landeira-Vinuela, Adrian Torres-Roda, Hector Lorenzo-Gil, Maria Gonzalez-Gonzalez, Angela P. Hernandez, Lucia Lourido, Ronald Sjoberg, Elisa Pin, Javier de Las Rivas, Jose Manuel Sanchez-Santos, Peter Nilsson, Francisco J. Blanco

Summary: Rheumatic diseases are common and complex conditions with low sensitivity to clinical diagnosis. This study developed an early diagnosis method for personalized treatment based on the identification of relevant proteins associated with the specific pathologies. By utilizing functional proteomics screening, a panel of 30 serum proteins has been identified as potential biomarkers for rheumatic diseases such as osteoarthritis, rheumatoid arthritis, and psoriatic arthritis.

JOURNAL OF PROTEOME RESEARCH (2023)

Article Oncology

Systematic Evaluation of Antigenic Stimulation in Chronic Lymphocytic Leukemia: Humoral Immunity as Biomarkers for Disease Evolution

Alicia Landeira-Vinuela, Miguel Alcoceba-Sanchez, Almudena Navarro-Bailon, Carlota Arias-Hidalgo, Pablo Juanes-Velasco, Jose Manuel Sanchez-Santos, Quentin Lecrevisse, Carlos Eduardo Pedreira, Marina L. Garcia-Vaquero, Angela-Patricia Hernandez, Enrique Montalvillo, Rafael Gongora, Javier de las Rivas, Marcos Gonzalez-Diaz, Alberto Orfao, Manuel Fuentes

Summary: Clonal B cell expansion in chronic lymphocytic leukemia may be triggered by persistent antigenic stimulation. Studying the dynamics of the humoral response in these patients can provide information about immunoglobulin levels and identify compromising antigens. This study offers a new perspective for patient stratification and targeted therapy selection.

CANCERS (2023)

Article Biochemistry & Molecular Biology

Comparative Analysis of Cell Mixtures Deconvolution and Gene Signatures Generated for Blood, Immune and Cancer Cells

Natalia Alonso-Moreda, Alberto Berral-Gonzalez, Enrique De La Rosa, Oscar Gonzalez-Velasco, Jose Manuel Sanchez-Santos, Javier De Las Rivas

Summary: In the past two decades, there have been many studies on complex biological samples that provide bulk expression signals but fail to identify specific genes in specific cell types due to cellular heterogeneity. To solve this problem, computational techniques have been developed to deconvolve cell mixtures and calculate the relative proportions of cellular components. This study implemented five deconvolution methods and analyzed blood, immune cells, and cancer cells in complex mixture samples. The results show that CIBERSORT is optimized for identifying immune cell types, while LINSEED provides precise gene signatures for immune cell types and cancer cells.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Hematology

Eltrombopag increases the hematopoietic supporting ability of mesenchymal stem/stromal cells

Sandra Muntion, Silvia Preciado, Elena Sanchez-Luis, Luis Corchete, Maria Diez-Campelo, Lika Osugui, Gerardo-Javier Marti-Chillon, Maria-Belen Vidriales, Almudena Navarro-Bailon, Javier De Las Rivas, Fermin Sanchez-Guijo

Summary: This study found that Eltrombopag (EP) not only has direct effects on hematopoietic cells, but also affects the function and properties of mesenchymal stem cells (MSCs), enhancing their ability to support hematopoiesis. These findings are important for the treatment of hematopoietic disorders.

THERAPEUTIC ADVANCES IN HEMATOLOGY (2022)

Article Biochemistry & Molecular Biology

Biological interacting units identified in human protein networks reveal tissue-functional diversification and its impact on disease

Marina L. Garcia-Vaquero, Margarida Gama-Carvalho, Francisco R. Pinto, Javier De Las Rivas

Summary: The centrality measures of individual proteins are insufficient to dissect the functional properties of cells, a more comprehensive, relational and context-specific method is needed. The study reveals tissue-specific functional diversification based on the identification of specific protein units.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2022)

No Data Available